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Abstract
Background: The insufficient understanding of unintended biological impacts from nanomaterials (NMs) represents
a serious impediment to their use for scientific, technological, and medical applications. While previous studies have
focused on understanding nanotoxicity effects mostly resulting from cellular internalization, recent work indicates
that NMs may interfere with transmembrane transport mechanisms, hence enabling contributions to nanotoxicity by
affecting key biological activities dependent on transmembrane transport. In this line of inquiry, we investigated the
effects of charged nanoparticles (NPs) on the transport properties of lysenin, a pore-forming toxin that shares fundamental features with ion channels such as regulation and high transport rate.
Results: The macroscopic conductance of lysenin channels greatly diminished in the presence of cationic ZnO NPs.
The inhibitory effects were asymmetrical relative to the direction of the electric field and addition site, suggesting
electrostatic interactions between ZnO NPs and a binding site. Similar changes in the macroscopic conductance were
observed when lysenin channels were reconstituted in neutral lipid membranes, implicating protein-NP interactions
as the major contributor to the reduced transport capabilities. In contrast, no inhibitory effects were observed in the
presence of anionic SnO2 NPs. Additionally, we demonstrate that inhibition of ion transport is not due to the dissolution of ZnO NPs and subsequent interactions of zinc ions with lysenin channels.
Conclusion: We conclude that electrostatic interactions between positively charged ZnO NPs and negative charges
within the lysenin channels are responsible for the inhibitory effects on the transport of ions. These interactions point
to a potential mechanism of cytotoxicity, which may not require NP internalization.
Keywords: ZnO, Nanoparticles, Lysenin, Ion transport, Electrophysiology, SnO2, Toxicity, Voltage gated channels,
Ligand gated channels
Background
The rapid development of certain nanomaterials (NMs)
has led to their extensive use in many commercial applications including cosmetics, sporting goods, automotive parts, and electronics [1–4], while many others are
under intense investigation for scientific, technological,
and biomedical applications [5–9]. The large surface area
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to volume ratio of these materials yields novel physical
and chemical properties that enable applications that are
unachievable using micron-sized bulk material of identical composition. The scientific community has spent
decades developing an understanding of NMs in order to
control their fundamental physical and chemical properties. However, early investigations demonstrated that
some of the same properties that make NMs attractive
for multiple applications may cause unintended hazardous interactions with biological systems. Therefore,
environmental and human exposure poses potentially
significant risks [10], and this paradigm has led to intense
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investigations on the potential biological impact of NMs
[11, 12]. While we have thus far attained a tremendous
body of knowledge on end-point effects such as cytotoxicity, neurotoxicity, genotoxicity and oxidative stress [13–
16], we lack a thorough understanding of the principles
by which modulation of size, charge, composition, dissolution levels and surface chemistry affect the interaction
of NMs with living cells.
ZnO nanoparticles (NPs) are considered to be one of
the more toxic of the metal oxide NMs [17, 18]. Studies
on ZnO NPs have demonstrated toxicity towards a large
number of cell lines and model organisms, however, the
mechanism of cytotoxicity is still under debate. Certain
physicochemical properties, such as surface chemistry,
dissolution potential, and their intrinsic ability to produce reactive oxygen species (ROS) have a strong impact
on their cytotoxic effects [19–21]. Several studies have
demonstrated that cytotoxicity stems from high dissolution rates, causing elevated levels of Z
 n2+ ions in cellular media that eventually disrupt homeostasis and
leads to cell death [22, 23]. Other groups have suggested
that their intrinsic ability to produce ROS (which may
arise from surface defects, such as oxygen vacancies) is
responsible for the high cytotoxic potential of ZnO NPs
[24, 25]. In the same line, S
 nO2 NPs have been shown to
inhibit kinetic growth and cytotoxicity towards certain
cell lines and organisms [18, 26, 27], while other publications have demonstrated modest to no cytotoxic effects
[28, 29]. Similar to other NPs, the crystal and hydrodynamic size of S
 nO2 NPs play an important role on their
toxic effects, and smaller sizes have been shown to correlate with increased toxicity [27].
Our inability to correctly predict how physical and
chemical properties relate to toxicity stems from the fact
that biological systems are elaborate and structurally and
functionally interconnected, making it very difficult to
isolate distinct interactions responsible for cytotoxicity.
Therefore, investigations utilizing a simplified model system that mimics the structure and function of a biological assembly can be an important step towards a more
complete understanding of mechanisms of nanotoxicity.
In these regards, we address how the directional flow
of ions across lipid membranes containing specialized
transmembrane ion transporters are affected by NPs.
This work is motivated by the tremendous biological relevance of ionic transport for any living cell, and by the
evidence that malfunctions of the mechanisms that control the transmembrane transport may have catastrophic
consequences for cell functionality [30].
Among transmembrane transporters, voltage-regulated channels play key roles in fundamental cellular processes such as creating and maintaining electrochemical
gradients, transmission of information, ion transport,
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signaling, and metabolism [31]. A salient feature of such
transporters is the regulation of their activity by transmembrane electric fields interacting with voltage-sensing
domains present in the channel’s structure [32]. The presence of charged domains in different regions of protein
channels presents opportunities for electrostatic interactions with charged NPs, which may affect the transmembrane transport and functionality of the host cells.
Given the large variety of ion transporters in the cell
membrane, isolating a particular one in a specific cell
for relevant studies on transport modulation induced
by NPs is not an easy task. Moreover, reconstitution of
a particular ionic transporter in an artificial membrane
system, although feasible, may require multiple, extensive and costly preparation steps. A simplified system featuring fundamental characteristics of ion channels may
constitute an excellent model for investigating potential
nanotoxicity effects originating from the disruption of
transmembrane transport of ions. Therefore, we propose
a simplified model that explores the effects of charged
NPs on the transport of ions through lysenin channels
inserted into an artificial bilayer lipid membrane (BLM).
Lysenin is a pore-forming protein extracted from the
coelom of the earthworm E. foetida, which self-assembles as a large conductance nonameric pore (~ 3 nm) in
artificial and natural lipid membranes containing sphingomyelin (SM) [33–35]. The recently deciphered crystal
structure indicates large charged domains present within
the channel [36, 37], thus presenting a strong potential for electrostatic interactions with charged NPs. The
physiological role of lysenin is still obscure but the cytolytic and hemolytic activity is indicative of a pore-forming
toxin [38]. Nonetheless, its relevance for nanotoxicity
studies stem from several remarkable biophysical properties it shares with ion channels. Unlike many other poreforming toxins and similar to voltage-gated ion channels,
lysenin channels present asymmetrical voltage-induced
gating [33, 39]. They adopt an open state at negative
voltages, while positive voltages larger than ~ + 20 mV
induce gating and closing [39, 40]. This salient feature is
complimented by reversible ligand-induced gating, manifested as conformational changes in the presence of low
concentrations of multivalent metal cations leading to
channel closure [41, 42]. Once the multivalent cations
bind and induce conformational changes, the channel
adopts a sub-conducting or closed state [41, 42]. Another
advantageous property of lysenin channels is that voltage
and ligand-gating properties can be easily discriminated.
This is achieved by reconstituting the channels in neutral
lipid membranes which maintains the ligand-induced
gating mechanism but renders lysenin unresponsive to
the applied voltage [41, 42]. The high transport rate of
lysenin channels yield large ionic currents which facilitate
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data recording and analysis. Lastly, lysenin channels are
easily reconstituted in artificial membrane systems containing SM, are stable for extended time periods, and the
monomer form of the protein is commercially available.

Methods
Chemicals and nanoparticles

Asolectine (Aso), cholesterol (Chol), SM (from
Sigma-Aldrich) and diphytanoyl phosphatidylcholine
(DiPhytPC, from Avanti Polar Lipids) were purchased
as powders and dissolved in n-decane at a final concentration of 50 mg/mL. For the support electrolyte, NaCl
(Fisher Scientific) was dissolved in nanopure water at
a final concentration of 130 mM (if not otherwise indicated) and buffered with 20 mM 4-(2-hydroxyethyl)1-piperazineethanesulfonic acid (HEPES) at pH = 7.2.
ZnO and SnO2 NPs were synthesized using wet chemical methods as previously described [43, 44]. Briefly, for
ZnO NP samples, the precursor zinc acetate dihydrate
(Zn[CH3CO2]2·2H2O) was suspended in diethylene glycol. The solution was heated and nanopure water was
added when the solution reached 80 °C. The temperature
was then brought to and held at 150 °C for 90 min. The
NPs were collected by centrifugation and subsequently
washed with ethanol. For SnO2 NPs, sodium stannate
(Na2[Sn(OH)6]) and urea were used as precursors with
nanopure water as the solvent. The solution was heated
to 90 °C and held for 90 min. The NPs were collected via
centrifugation and subsequently washed with nanopure
water. Characterizations were performed using X-ray
diffraction (XRD) (Additional file 1: Fig. S1), transmission electron microscopy (TEM) (Additional file 1: Figs.
S2, S3), zeta potential (ZP) measurements, dynamic
light scattering (DLS) (Additional file 1: Fig. S4), X-ray
photoelectron spectroscopy (XPS) (Additional file 1:
Fig. S5) and Fourier-transform infrared spectroscopy
(FTIR) (Additional file 1: Fig. S6). XPS confirmed sample purity and atomic concentrations for stoichiometric
ratios. XRD was employed to ensure crystal phase purity
and to obtain average crystalline size for both samples.
XRD confirmed the expected hexagonal wurtzite crystal
structure for ZnO and cassiterite for S
 nO2. The average
crystal size for ZnO and S
 nO2 NPs was analyzed with
Rietveld refinement using Materials Analysis Using Diffraction (MAUD) software and estimated at 8.3 ± 2 and
4.3 ± 0.04 nm respectively. A JEOL JEM-2100 HR analytical TEM was used to confirm spherical morphology
and average crystal sizes. FTIR spectra was collected
using a Bruker Tensor 247 spectrometer and FTIR pellets
were produced by first grinding 1.6 mg of each NP sample with 0.200 g of spectroscopic grade KBr. The ground
powder mixture was then pressed with 8 tons of pressure
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for 3 min and pellets were analyzed after removing the
KBr background. Zeta potential and DLS measurements
were performed, after dispersing the powders in nanopure water at a concentration of 1 mg/mL, using a Malvern Zetasizer NanoZS. ZnO NP clusters had an average
hydrodynamic size (HDS) of 276 nm and average ZP of
+ 32 mV, whereas SnO2 NP clusters average HDS was
176 nm with an average ZP of − 42.0 mV.
Bilayer lipid membrane setup

The experimental setup employed the use of a planar
BLM chamber consisting of two polytetrafluoroethylene (PTFE) reservoirs separated by a thin (~ 120 μm)
PTFE film that had been pierced with an electric spark
to create a circular hole of ~ 70 µm diameter [45, 46].
The reservoirs were filled with 1 mL buffered electrolyte and connected via two Ag/AgCl electrodes inserted
in the solution to an Axopatch 200B amplifier (molecular devices). The amplified analog signal fed the DigiData
1440A digitizer (molecular devices) which provided the
digital signal for visualization, recording, and further
analysis. Continuous stirring of the solutions in the BLM
chamber was assured by a low-noise magnetic stirrer
(Warner instruments). All the experiments were performed in voltage-clamp mode upon manual or automatic voltage stimulation. The signal recorded during
various voltage stimulations was further analyzed with
ClampFit 10.6.2.2 (Molecular Devices) and Origin 8.5.1
(Origin Lab) software packages.
Experimental procedure

Lipid membrane preparation was performed by “painting” the hole in the PTFE film with small amounts of
lipid mixtures composed of 4 mg Aso or DiPhytPC, 2 mg
Chol, and 2 mg SM dissolved in ~ 400 μL n-decane [46,
47]. The successful creation of the BLM was indicated by
measuring the capacitance in response to an applied triangular voltage stimulation, while achievement of a seal
resistance larger than 1000 GΩ was assessed by measuring the leakage current in response to a DC voltage
stimulation (100 mV). Channel insertion was performed
by adding the lysenin monomer (from Sigma-Aldrich,
0.3 nM final concentration) to the ground (cis) reservoir
under continuous stirring and at − 60 mV bias potential
applied to the trans (headstage) reservoir. The application
of a negative voltage was required to prevent the voltageinduced gating which manifests at positive transmembrane potentials [33, 39, 40]. After the insertion process
was completed, as indicated by a steady state value of the
open current, an extensive flushing of the cis reservoir
with lysenin-free electrolyte was performed to remove
the bulk monomer and prevent additional insertions.
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To avoid potential changes in the lysenin functionality
originating in congestion effects [48], the total number
of channels inserted into the membranes was limited
to ~ 1000. To facilitate quantitative comparison of the
influence of NPs on the transport properties of lysenin
channels in parallel experiments comprising different numbers of inserted channels, we used the relative
changes in the macroscopic conductance (Gr = G/G0)
for data plotting, where G is the conductance after addition of NPs and G0 is the conductance before addition. In
order to avoid premature dissolution and/or aggregation,
the NPs (powder form) were dispersed by sonication for
5 min in the support electrolyte solution in a sonication
bath before each addition to the reservoirs.

Results and discussion
Once a steady state current through the population of
lysenin channels was achieved, the NPs were introduced
into either side of the chamber with both negative and
positive voltages applied across the membrane to assess
their effect on the macroscopic conductance (see Fig. 1
for a schematic of the setup). The addition of ZnO NPs
(20 µg/mL final concentration) to either side of the
membrane containing lysenin channels, when biased by
− 60 mV, yielded only a modest decrease of the macroscopic conductance, i.e. a few percent, irrespective of the
side of addition (Fig. 2). This slight decrease in the conductance suggests a minimal influence of ZnO NPs on
the lysenin channels’ ability to transport ions in these
particular experimental conditions.
To explain the small reduction in conductance, one
may hypothesize several different mechanisms such as
ligand gating induced by small amounts of Z
 n2+ ions
provided from low NP dissolution, ligand gating induced
by NP binding to a specific binding site, or physical

Fig. 1 The experimental setup comprises lysenin channels reconstituted into planar lipid bilayer membranes. The modulation of ionic
transport and regulation by ZnO NPs is assessed in classic voltageclamp experiments
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occlusion by transient NP attachment to the opening of
the nanopore. Past investigations show a dramatic yet
reversible decrease of the macroscopic conductance of
lysenin channels in the presence of low concentrations of
multivalent cations [41, 42], indicative of strong interactions with lysenin channels. Those interactions have been
elucidated in single-channel experiments, which provide
evidence of gating, i.e. transition from the open state
to a sub-conducting or closed state [41, 42]. To explain
lysenin’s reversible gating in the presence of multivalent
cations, it is assumed that the channel’s structure contains at least one negatively-charged binding site with
high affinity for cations, which triggers gating upon binding. A potential leakage of Z
 n2+ ions from NPs may affect
the macroscopic conductance of lysenin channels, as
observed. In addition, if exposed this binding site could
electrostatically interact with cationic NPs and yield a significant decrease in conductance either by induced gating
or physical occlusion of the conducting pathway. However, such strong effects were not observed in the above
experimental conditions, which prompted us to look
closer to the lysenin’s structure for alternative explanations. The assembled lysenin channel shows the presence
of multiple anionic domains [36, 37, 49], hence presenting opportunities for physical occlusions of the channels
through electrostatic interactions even in the absence of
gating. We may account for the weak conductance inhibition by considering the position of a binding site and
the orientation of the external electric field. A deep-buried binding site would be inaccessible from either side to
NPs larger than the channel’s diameter (~ 3 nm), which
is mostly the case in our investigations. Nanoparticle
interaction with a binding site present at the trans opening of the channel would be prevented at − 60 mV by the
electric field orientation. Although the electric field in
the bulk is very low, its amplitude increases substantially
when approaching the channel opening (fringe effects),
therefore keeping the NPs far from a binding site located
at the cis opening. The same electric field will drive the
NPs added to the cis side towards the membrane but the
lack of changes in macroscopic conductance suggest the
absence of a binding site at this location. The hypothesis
of an exposed binding site at the trans opening was further sustained in similar experiments comprising trans
NP addition and no transmembrane voltage; in such
experimental conditions, a marked decrease of the macroscopic conductance was observed at − 60 mV after 2 h
of NP incubation in the absence of a bias potential (data
not shown). However, this result could be an artifact
originating from dissolution during the prolonged NP
exposure to the electrolyte solution.
To identify if the elusive binding site is located
either deep within the channel or at the trans side, we
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Fig. 2 ZnO NPs do not alter the ionic conductance of lysenin channels when biased by a − 60 mV transmembrane voltage. Addition of ZnO NPs
to either trans (a) or cis (b) reservoirs induces only negligible changes of the macroscopic conductance. The experimental values are reported as
mean ± SD, n = 3. All the data points represent experimental values but some symbols have been removed for improved visibility

performed the experiments under positive bias potentials
(Fig. 3). After the channel insertion process, the influence of ZnO NPs was assessed in experiments comprising of cis or trans addition and opposite orientations of
the electric field. Lysenin channels are voltage-gated at
positive voltages greater than ~ + 20 mV but are stable in the open state for extended time periods as long
as the applied voltage is less than this critical value [33,
39]. Interestingly, addition of ZnO NPs to the trans
side under positive biasing (+ 15 mV to prevent voltage

Fig. 3 Interactions between lysenin channels and ZnO NPs at
+ 15 mV bias potential. Cis addition (green) of ZnO NPs yield minor
changes in the macroscopic conductance. In contrast, trans addition
(blue) elicits a significant decrease of the macroscopic conductance
by ~ 70%. The experimental values are reported as mean ± SD, n = 3.
All the data points represent experimental values but some symbols
have been removed for improved visibility

gating) induced a rapid and sustained decrease of the
macroscopic conductance (Fig. 3), while cis addition
elicited only a weak response in otherwise similar conditions. Consequently, we concluded that the electric field
plays a major role in preventing ZnO NPs accumulation
near the membrane when biased by − 60 mV. However,
in the absence of an electric field or when positive voltages are applied, ZnO NPs may interact with a binding
site situated at the trans opening of the channel.
Dissolution of ZnO NPs can result in high extracellular Z n2+ concentrations which have been proposed
as one of the main mechanisms of ZnO NPs cytotoxic
effects [22, 23, 50]. Zinc ions inhibit the macroscopic
conductance of lysenin channels by a ligand-induced
gating mechanism [41, 42]. Due to the high sensitivity of lysenin channels to Z n2+, dissolution may explain
the observed inhibition of conductance upon exposure
to ZnO NPs. To eliminate such potential experimental
artifacts, we performed investigations in similar conditions but added Z
 n2+ ions (ZnSO4; 2 mM final concentration) to the reservoirs instead of ZnO NPs. Addition
of Z n2+ to either side, biased by − 60 mV, yielded a sudden decrease of the macroscopic conductance in agreement with previous reports (Fig. 4) [41, 42]. Addition
of the same amount of Z n2+ to a similar BLM containing lysenin channels and biased by + 15 mV (to prevent voltage-induced gating) yielded a similar relative
decrease of the macroscopic open current (Fig. 4). If
conductance inhibition elicited by ZnO NPs had been
induced by the Z n2+ ions dissipating from the NPs, then
addition to either side would have displayed a similar
pattern of conductance inhibition. However, addition of
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Fig. 4 Zn2+ ions decrease the macroscopic conductance of lysenin channels irrespective of bias potential and site of addition. At + 15 mV
transmembrane voltage (a), Zn2+ addition to either the cis or trans reservoir reduces the macroscopic conductance by ~ 40%. Similar decreases are
recorded upon Z
 n2+ interactions with lysenin channels biased by − 60 mV (b). The presented data represents a typical run for each experiment

Z n2+ ions yielded fundamentally different results compared with the experiments involving ZnO NPs. Z n2+
ions affected the macroscopic conductance irrespective
of the side of addition and direction of the electric field,
while the inhibitory activity of ZnO NPs depended on
both these experimental parameters. The total concentration of ZnO NPs was only 20 μg/mL (corresponding
to ~ 0.25 mM Z n2+ ions) and resulted in a 70% decrease
in the macroscopic conductance. In order to obtain an
approximate decrease of only 45% in conductance measurements with Z n2+ ions, the experiment employed a
final concentration of 2.0 mM. Assuming complete dissolution of ZnO NPs, this would correlate to approximately eight times the amount of Z
 n2+ ions from Z
 nSO4
in the solution. To further eliminate the possibility that
the Z n2+ ions contributed to the observed conductance
inhibition, experiments with ZnO NPs were carried out
in the presence of the strong Z n2+ chelator EDTA. EDTA
(10 mM) was added to the solutions prior to nanoparticle addition, thus effectively preventing any interactions
of the free zinc ions from the NPs with lysenin channels.
These experiments yielded almost identical decreases
in the macroscopic conductance when compared with
ZnO NPs with no EDTA (Additional file 1: Fig. S7).
Our results clearly indicate that the conductance inhibition elicited by ZnO NPs was not a consequence of
Z n2+ ions from dissolution. These experiments revealed
that the extent of the conductance inhibition depended
on both the orientation of the lysenin channels and the
electric field relative to the site of ZnO NP addition. The
observed conductance inhibition may originate from
local accumulation of NPs by electrophoretic effects,
specific interactions with the membrane itself, or preferential interactions with binding sites of lysenin.

Next, we asked whether or not exposure to ZnO NPs
changes the voltage-induced gating profile. To answer
this question, the voltage-induced gating of lysenin channels was assessed from the I–V plot recorded in the range
− 60 to + 60 mV (Fig. 5) at a voltage rate of 0.2 mV/s
with and without the addition of ZnO NPs. The macroscopic current recorded in absence of NPs (Fig. 5) featured the well-known characteristics of voltage-induced
gating, i.e. a linear behavior in the negative voltage range,

Fig. 5 Effects of ZnO NPs on lysenin voltage-induced gating. In the
absence of NPs, lysenin channels begin to close at transmembrane
potentials greater than 20 mV (green curve). ZnO NPs (20 µg/mL final
concentration) almost completely abrogate the conductance in the
positive voltage range (blue curve) and indicate a strong interaction
with the lysenin channels. All points on the curves are experimental
data and symbols have been added for discrimination. The presented
data represents a typical run for each experiment
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indicative of the absence of gating, and a non-linear
behavior at positive voltages higher than + 20 mV, indicative of channel closure [33, 39, 40]. A typical feature of
the macroscopic current recorded at positive voltages is
the transition from high current to low current through a
dynamic negative resistance region [39, 40]. The macroscopic currents recorded in the same voltage range after
addition of ZnO NPs (20 µg/mL final concentration) to
the trans side of the membrane yielded a fundamentally
different I–V plot (Fig. 5). The addition of ZnO NPs elicited a slight decrease in the open current recorded in the
negative voltage range, however, the I–V characteristic
preserved quasi-linearity between − 60 and − 20 mV.
Once the voltage approached neutral values, the macroscopic current greatly deviated from the control I–V
plot and the ionic transport capabilities of lysenin channels were strongly diminished in the presence of ZnO
NPs. Interestingly, the macroscopic conductance started
to decrease at small negative voltages, as indicated by
the diminished slope of the I–V plot. This is consistent
with the hypothesis that the fringe effect of the electric
field prevents the NPs from interacting with the binding
site. The magnitude of the electric field decreases with
decreasing applied voltage and the weak electrophoretic
force, although opposed, is not sufficient to prevent interactions with the binding site and channel conductance
modulation. The consistently lower macroscopic currents indicated that addition of ZnO NPs induced severe
channel conductance inhibition as demonstrated by the
large decrease of the macroscopic current at any positive voltage. At positive voltages, the currents recorded
in the presence of ZnO NPs were consistently lower than
the currents recorded in the absence of ZnO NPs up to
~ + 40 mV, after which the recorded currents were similar to the control when the channels are in a closed state.
This experiment demonstrated that ZnO NPs affect
the macroscopic conductance of lysenin channels in a
voltage-dependent manner but it does not offer a complete mechanistic description. The significant changes
in the I–V curve after addition of ZnO NPs potentially
stem from multiple mechanisms. Experimental evidence
and theoretical modeling have demonstrated that electrostatic interactions between membrane components
and NPs are key factors that contribute to toxicity and
the ability of NPs to internalize into cells [51–53]. Our
experiments comprised a simple system consisting of lysenin channels inserted into an artificial BLM composed
of charged lipids. We assumed that the conductance of
lysenin channels was affected by interactions between
the protein channels and NPs but we could not exclude
interactions between the charged lipids and ZnO NPs as
a source of conductance modulation. The Aso lipid mixture used for BLM preparation contains several anionic
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components that may interact electrostatically with
voluminous cationic NPs unable to penetrate the lumen,
which would lead to channel conductance modulation.
To elucidate the potential role played by the charged
lipids, we performed experiments by replacing Aso with
neutral DiPhytPC. The use of neutral lipids abolishes the
voltage-induced gating at positive voltages while preserving the ligand-induced gating observed in the presence
of multivalent cations [41, 42]. Addition of ZnO NPs to
the cis side of a neutral membrane containing lysenin
channels and biased by + 60 mV elicited no change in
the macroscopic conductance (Fig. 6). However, addition of ZnO NPs to the trans side of the same membrane,
biased by an identical positive voltage, yielded a massive
decrease in conductance similar to the results obtained
using charged lipids (Fig. 6). The non-symmetrical
response and preservation of the inhibitory capabilities
of ZnO NPs recorded for the neutral BLM suggest that
the inhibition mechanism excludes electrostatic interactions between NPs and lipids. The interaction between
lysenin channels and ZnO NPs is therefore likely responsible for the observed inhibitory activity.
We have shown that lysenin channels interact with positively charged ZnO NPs but have not yet demonstrated
the electrostatic nature of those interactions. Therefore,
we asked whether or not any NPs electrophoretically
driven towards a specific or non-specific yet accessible
binding site would interact with lysenin channels and
inhibit their conductance. In this respect, we performed

Fig. 6 Lysenin channels reconstituted in neutral lipid membranes
interact with ZnO NPs at + 60 mV transmembrane voltage. Cis addition of ZnO NPs elicits no changes in the macroscopic conductance.
In contrast, ZnO NPs added to the trans reservoir interact with lysenin
channels and significantly diminish their ionic transport capabilities.
The experimental values are reported as mean ± SD, n = 3. All the
data points represent experimental values but some symbols have
been removed for improved visibility
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conductance experiments by replacing positively charged
ZnO NPs with negatively charged SnO2 NPs (− 42 mV
ZP). Irrespective of the applied voltage and the addition
site, SnO2 NPs did not affect the macroscopic conductance of lysenin channels (Fig. 7). In order to try to elicit
interactions with SnO2 NPs, 200 μg/mL (final concentration) of SnO2 NPs were used, which is 10× the concentration of ZnO NPs that induced rapid decreases in the
macroscopic conductance (Fig. 3). The crystal and hydrodynamic sizes of SnO2 NPs used in this experiment were
much smaller than ZnO NPs, suggesting that S
 nO2 NPs
would be better suited to inhibit conductance by physical occlusion. The absolute magnitude of the ZP for SnO2
NPs was also larger than ZnO NPs, further strengthening the hypothesis of a mechanism that requires strong
electrostatic interactions between cationic ZnO NPs and
an anionic domain present at the trans side of the lysenin channel to induce conductance inhibition. Also, to
further support the hypothesis that electrostatic interactions between the lysenin channels and ZnO NPs initiate
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a decrease in conductance, we investigated the effects of
electrostatic screening induced by an increased ion concentration in the bulk electrolyte solutions. Addition of
20 µg/mL ZnO NPs to the trans side of the bilayer containing lysenin channels in 500 mM NaCl and under
positive bias reduced the conductance by ~ 15% (Additional file 1: Fig. S8), which is much smaller than what
we observed at 130 mM NaCl concentration (~ 70%,
Fig. 2). In addition, the time required to reach equilibrium increased to more than 2500 s, indicating that ionic
screening weakened the interactions between NPs and
lysenin channels, and supporting the hypothesis that
electrostatic interactions are at the origin of the observed
changes in conductance. However, we may not eliminate
potential artifacts arising from the effects of screening on
the ZnO NPs. At high salt concentration, screening may
accelerate NP aggregation, which is what we observed
when attempting to further increase the ionic concentration of the bulk electrolyte solutions. The ZnO NPs
rapidly aggregated into large clusters at the bottom of

Fig. 7 Interactions between anionic SnO2 NPs and lysenin channels reconstituted into a planar bilayer lipid membrane. Addition of S nO2 NPs to the
trans reservoir at − 60 mV (a) and + 15 mV (b) indicates insignificant changes of the macroscopic conductance. Similarly, S nO2 NP addition to the
cis reservoir at − 60 mV (c) and + 15 mV (d) yields negligible changes in the ionic transport capabilities. The presented data represents a typical run
for each experiment
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the vials in a matter of minutes, which prevented further
experimentation in high ionic strength conditions.
A few assumptions can be proposed about the mechanism responsible for the observed decrease in macroscopic conductance elicited by addition of ZnO NPs.
Electrostatic interactions may bring ZnO NPs close
enough to the channels such that the resulting physical blockage reduces the individual currents. In such
case, an opposite electric field of appropriate magnitude
may drive the NPs away from the binding site therefore
unblocking the channels. Our attempts to apply higher
voltages across the BLM and to force the unblocking
were not successful. However, it is possible for the binding site to have a relatively strong affinity for charged
ZnO NPs and consequently the force required to remove
the NPs from the binding sight may require much higher
electric fields. Unfortunately, such experiments are very
difficult to achieve as the BLM is prone to disruption at
high transmembrane voltages.
Another potential inhibition mechanism mimics
ligand-induced gating. It has been established that lysenin channels interact with multivalent cations and
undergo conformational transitions that force the channel into closed or sub-conducting states [41, 42]. This
ligand-induced gating mechanism relies on electrostatic
interactions between cations and one or more binding
sites but ionic current blockage stems from the induced
gating. It is possible that charged ZnO NPs interact electrostatically with one or more binding sites, yet not necessarily the same one(s) involved in the ligand-induced
gating and would force the channels to adopt a sub-conducting or a closed state. Lastly, defects on the surface of
ZnO NPs such as oxygen vacancies have been shown to
correlate with ROS production [24, 54]. Since the electrostatic interactions induce close contact of ZnO NPs with
the channels, the highly reactive surface of ZnO NPs may
interact with cysteine and methionine residues in their
structure which may alter channel functionality and conduction similar to reports of oxidation of cysteine residues in C
 a2+/K+ channels [55, 56].

Conclusions
Our work demonstrates that the transport properties
of lysenin channels change significantly in the presence of cationic ZnO NPs. The modulation of the transport properties by NPs is strongly dependent on the net
charge, and the orientation of the electric field and channel with respect to the NPs. There is little doubt that the
primary interaction between NPs and lysenin channels is
electrostatic. Nonetheless, the simplicity of the experimental system investigated here does not necessarily
warrant biological interpolation to other protein channels interacting with NPs, not even ZnO. In complex
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biological environments, the binding of various functional groups on the NP surface may significantly alter
their ability to interact with membrane components irrespective of the surface charge of the pristine nanomaterial. Given the aggregation tendency of the investigated
NPs, we may not exclude aggregation at the membrane
surface as being at the origin of conductance changes.
Even the neutral lipids used for our investigations present
a dipole moment that may initiate NP binding; further
NP aggregation at these binding sites may impede the
ionic flow by physical occlusion or by introducing supplementary electrostatic energy barriers for ions. However, if an induced dipole moment that initiated binding
of NPs to lipids occurred, then SnO2 NPs should have
yielded a similar response due to their higher net charge.
Nonetheless, dipole–charge interactions have a much
smaller magnitude than the charge–charge ones, and we
did not observe such effects when using neutral lipids.
In spite of these shortcomings, an important conclusion
of this report pertains to the potential ability of NPs to
interact with transmembrane transporters without the
need of internalization. Many previous studies assume
that cytotoxic effects of NPs are due to translocation of
NPs into the cytosol by various transport mechanisms
and/or dissolution of the NPs, disrupting homeostasis
and interfering with vital cellular processes. Our work
suggests that NPs may tamper with ionic transport
mechanisms by basic electrostatic interactions. Given
the physiological relevance of controlled transmembrane
transport, such alterations may have catastrophic effects
for cells. While this observation is generally valid for any
cell, it may prove extremely helpful for understanding the
potential neuro-toxic effects of NPs [57]. The physiology
of the neural cell is based on the transport properties and
regulation of voltage-gated ion channels, which are transmembrane structures with multiple charged domains
that may interact electrostatically with NPs. Changes in
the voltage-induced gating mechanism or blockage of
ionic transport induced by NPs [57] may dramatically
affect the correct functionality of the nerve cell. Such
interactions may explain why certain NPs specifically
alter the individual currents through specific channels
while the transport properties of other channels are not
affected by various NPs [58, 59]. The local distribution of
charge within the structure of several ion channels is currently known so it may be possible to predict potential
toxic effects based on interactions with charged NPs, or
to design NPs intended to alter the activity of transmembrane transporters.
This foray into deciphering the effects of NPs on the
transmembrane transport of ions indicates alterations in
the transporters’ functionality as a potential mechanism
of cytotoxicity. A previous study shows that ZnO NPs
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may induce neuronal cytotoxicity and genotoxicity in the
absence of internalization or free Zn2+ ions released from
the NPs [60]. Future experiments will shed more light on
intimate mechanistic details and the role that electrostatic interactions play in modulating the biological activity of protein channels.

Additional file
Additional file 1. Additional material that includes complementary
figures of material characterization (Figs. S1–S6: XRD, TEM, DLS, XPS, and
FTIR for ZnO and SnO2 NPs), changes in relative macroscopic conductance
of lysenin channels in the presence of ZnO NPs and EDTA (Fig. S7), and
conductance inhibition at high ionic strength (Fig. S8).
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